Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis

Clinical trial NCT03283826 · TERMINATED

Trial details

NCT number: NCT03283826
Sponsor: Atara Biotherapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Progressive Multiple Sclerosis Secondary Progressive Multiple Sclerosis

Start date: 2017-10-19
Primary completion: 2023-11-09
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.